year-end Kim, and call. conference and fiscal Cooper you, quarter XXXX welcome, Thank fourth Companies to everyone,
XXth posting almost quarter positive a consecutive our by fiscal launching lot gaining billion, XXXX tremendous year with our CooperSurgical growth. strategic fertility revenues and record Truly focus and executing driving driven market CooperVision a posting was maintaining culture. finished organic double-digit we on by really objectives, on all-time quarter fantastic as services note for of business We've closed consecutive and Cooper we growth Cooper year its XXth a of its organic share, of including posting innovative with $X.X revenues fantastic This products the phenomenal quarterly of excitement now on teams. long-range double-digit and entered with accomplishments and our profitability record
organically, share in XX%. of numbers. per the up hydrogel million, CooperSurgical's up $XXX strength our was Consolidated XX% $X.XX, posted Moving organically. daily revenues earnings of million, CooperVision's organically $XXX $XXX were to and by quarter million, led were growth posted a our growth solid fertility X% CooperVision profits was revenues with very X% and CooperSurgical non-GAAP revenues quarterly year-over-year. business. portfolio, Margins by strong and improved, silicone led up in of up
our innovative For grew CooperVision, and flexibility and The having key all accounts. success XX%, XX%, in products, percentages diversified. organic growth and X% market-leading growth with X strong with was an grew EMEA basis, all grew Asia revenue reporting Americas regions Pac and on
Avaira our Within grew lenses categories, non-single-use and monthly silicone modalities, Within and daily grew grew multifocals torics grew other grew X-week Vitality sphere X%. silicone grew XX%, and single-use XX%, XX%, sphere Biofinity lens X%. X% hydrogel and hydrogel
outperform product passed our including outstanding. on daily patient, multifocal rate it just pace very launch, this a MyDay. This high-growth silicone our expectations pairs continue results We the with for of the portfolio, the a shows doctor with high XX% growth fit and starting and satisfaction products multifocal to fitting and success of X-year easy momentum. makes remains the has MyDay win in anniversary or of system and in with design paired X an unique hydrogel combination in levels, resulted and less. an The the we to advanced Turning it
shared From I that. up, as how market, to the don't amazed in these and I a as and on and the the And I multifocal personal how as fantastic certainly multifocals, be lenses soon lenses and take out I biased, are continue and at time. sales I and I insert I may last growth these perspective, easy my remove vision quarter, until now best are MyDay distance put wake near to them I are. lenses bed supports believe but be our wear truly
across the and strong, our rollout MyDay following expansion toric, and product's mirrors the industry-leading remains market-leading to toric Europe. is due which design parameter of range. America SKU to our demand North Biofinity's Moving very design, success This
product In that our innovative eye most most continues designed care XXXX lenses digital U.S. say a practitioners patients recently fantastic care boost expectations. with recent and lifestyle. and our for recognition an to accomplishment MyDay team. innovative MyDay voted exceeding Energys, our impress was eye its to I'm today's And The are comfort, Energys and of specifically launch awesome practitioners, great sales by technology for digital deliver proud the
soon success products, these in as MyDay capacity rolling of out we the additional markets the certainly to around With world allows. forward look them as
segment, comfort, driver a which spheres, a to we're lens torics initial of with a key and continues wearers. positioning to the The multifocals growth for have price to offers daily excellent clariti of clariti great be continuing handling family full new have be price point. success MyDay while led silicone and And choice in our at
coming by strong excited remains announce highly successful I'm launching be several our by Biofinity our And the we'll dailies, to extremely to Biofinity family Avaira nice toric multifocal new year torics. quarter markets torics in of a products Outside demand led also of response to had led healthy, multifocals. and in for demand.
to in $XX China. the EMEA, XX% growth with myopia Pac due by Americas another to while revenues challenges for MiSight of posted in MiSight, This We up was up and Asia Moving powered management. million, was flat quarter excellent XX%.
fiscal growth has region the enter Americas showing excellent Pac hurdled EMEA growth trends. orders with past in the stocking we're and already the XXXX, returning we continuing as improving trends expecting and Asia is and positive As to
Additionally, rates, up and see over products. very being we're nice effect to adds world a our high key All halo this and retention in children other around accounts momentum growing XXX,XXX on to MiSight continuing momentum wearing the strong.
differentiator eye cataracts, retinal detachment along the myopia, to reduce only macular with as a clinical health K of proactive myopia remains first FDA-approved of extensive progression care reducing year-over-year. lens degeneration. and myopia quarter, with the a control, had such management associated in community eye rebound it's becomes the as children, by within standard growing and MiSight help problems This the for myopia contact data. crucial care is of backed our and nice XX% Ortho of Meanwhile, risk long-term franchise the
share lens roughly CooperVision finish X% QX, taking CooperVision, grew contact calendar To on XX%. market in with growing the
our the this, up When many kids of have is focus We you macro higher-value expect remain on the population growth time expect the Within correction. will of healthy, years pricing, combine remain XXXX, digital to XX% X% our and shift coming trend launches, Fit myopia by to product to indoors It's strength growing this growth needing greater expect portfolio, myopia to driven Data. for New a leader estimated solid management by fast-growing more X% in ongoing and products that ongoing vision toric from the the products, this robust innovation, XX% leading with market premium our other silicone we people of product long-term screens multifocal and by today. of industry. with the use hydrogel global roughly year, increasing business more factors. and supported spending among related the we This higher dailies, the year
consecutive CooperSurgical. growth. and revenues services, consumables, This of we share this, quarter up our by which sales market-leading X% up was around Moving portfolio, products including throughout organically, world of reproductive posted our testing. We $XXX record of to organic double-digit our the genetic capital saw and million, XX% driven $XXX and Within fertility gains million, included equipment organically. XXth
geographic in R&D. accounts key expansion, and We continued also investing
entering new of and extensive portfolio training expanding geographies, 'XX great excellence, sites, well centers team, fastest-growing existing to companies most one world. and we're We're fertility and developing diverse of fiscal donor and new as the and launching our delivering given continue momentum. through providing positioned opening in products, our in We're global the innovative new success,
and male fertility developed with technology assistance and benefits age fertility starting other include improving patient awareness, and the in For in old several for improvements drivers Other moving XX growth median fertility remain and broader years to roughly Age the market, increasing the to and factor challenges. growth women and coverage fertility treatment, contributing address delaying the macro first a access need U.S. the key to birth women's higher. both increasing is within of is countries female trends intact, childbirth.
the X Health Organization X/X of of is a future. continue infertility are of data combination X in underlying affected by lot is given globally World that of or is cause and to at women, men an is so point issue infertility a that two X/X this the And do their unknown, in The X/X lives. some that people impacts highlights people will the in and
of very acquisition X% and Cook our this growing from surgical. challenging we of several highly products office medical Medical. to up closed a with the $XXX million, against posted Within organically of sales devices Moving part recently We business, X% comp. strategic
results flat be forward success the decline sales. several this acquired X% future unit look us, higher on Given will delivery the device team strength deal and for a products solid space, having in offset pricing of labor in and of we're great I cell these to and and growth our was medical PARAGARD these Stem where posted reporting reside, of products. as storage the
a in born To CooperSurgical making say We're we being take and that's special able lives, is makes part CooperSurgical, really pride business what products. minute conclude to the people's for world, a difference that baby somewhere of this us. great our around every using
XXXX. fiscal to Moving
revenue will guidance, Let rest and the cover P&L. the Brian of me provide comments on
We limiter for to post new demand, to this guiding revenue wearer growth expect for The MyDay. and to CooperVision organic growth challenges year. are to from main the is X% strong results capacity X% especially
We around expect for the X% resulting of revenues in in constraints these quarter. QX, growth pressure capacity fiscal to
we move We capacity actively the high though online, are through year. growth report double-digit as and single-digit additional to to expect bringing
year Fertility, in we're stem and guiding volumes. ] which growth organic low to year and medical declining includes storage in growth of strength flat X% slightly due to [ of down another revenue cell to full CooperSurgical, PARAGARD to X% For mid-single-digit devices in to
entered with without possible is our great dedication the this To incredible conclude, we've let fiscal was work me for of of momentum. year a this Cooper, hard none great and say XXXX and employees. But
for team incredible Cooper So a year. global another thank to big you the entire
turn I'll the to now And Brian. call over